DENVER, May 9, 2023
/PRNewswire/ --ViewRay, Inc. (NASDAQ: VRAY) announced today details
relating to the release of first quarter 2023 financial
results.
ViewRay will hold a conference call to discuss results on
Wednesday, May 10, 2023 at
4:30 p.m. ET. The dial-in number is
(833) 470-1428 for domestic callers. The confirmation number is
133683. A live webcast of the conference call will be available on
the investor relations page of ViewRay's corporate website at
https://investors.viewray.com/events-and-webinars.
After the live webcast, a replay will remain available online on
the investor relations page of ViewRay's website under "Events and
Webinars."
About ViewRay®
ViewRay, Inc. (Nasdaq: VRAY) designs, manufactures, and markets
the MRIdian® MR-Guided Radiation Therapy System. MRIdian is built
upon a proprietary high-definition MR imaging system designed from
the ground up to address the unique challenges and clinical
workflow for advanced radiation oncology. Unlike MR systems used in
diagnostic radiology, MRIdian's high-definition MR was
purpose-built to address specific challenges, including beam
distortion, skin toxicity, and other concerns that potentially may
arise when high magnetic fields interact with radiation beams.
ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
View original
content:https://www.prnewswire.com/news-releases/viewray-announces-conference-call-for-first-quarter-2023-financial-results-to-be-held-after-market-on-may-10-2023-301819978.html
SOURCE ViewRay, Inc.